Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,098 | -7,101 | -38,371 | -26,009 | -22,132 |
| Depreciation Amortization | 1,153 | 576 | 4,089 | 3,063 | 2,036 |
| Accounts payable and accrued liabilities | -4,175 | -2,031 | 2,223 | 2,741 | 942 |
| Other Working Capital | -11,238 | -7,758 | 2,763 | 5,058 | -877 |
| Other Operating Activity | 6,516 | 3,231 | -10,034 | -11,340 | 2,809 |
| Operating Cash Flow | $-19,842 | $-13,083 | $-39,330 | $-26,487 | $-17,222 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 11,410 | 7,211 | 23,349 | 9,826 | 9,469 |
| PPE Investments | -2 | N/A | -13 | -13 | -16 |
| Investing Cash Flow | $11,408 | $7,211 | $23,336 | $9,813 | $9,453 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,384 | 7,217 | 1,034 | 445 | 435 |
| Financing Cash Flow | $7,384 | $7,217 | $1,034 | $445 | $435 |
| Exchange Rate Effect | -45 | -27 | -61 | -47 | -24 |
| Beginning Cash Position | 6,105 | 6,105 | 21,126 | 21,126 | 21,126 |
| End Cash Position | 5,010 | 7,423 | 6,105 | 4,850 | 13,768 |
| Net Cash Flow | $-1,095 | $1,318 | $-15,021 | $-16,276 | $-7,358 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,842 | -13,083 | -39,330 | -26,487 | -17,222 |
| Capital Expenditure | -2 | N/A | -13 | -13 | -16 |
| Free Cash Flow | -19,844 | -13,083 | -39,343 | -26,500 | -17,238 |